Mesenchymal Cancer Cell-Stroma Crosstalk Promotes Niche Activation, Epithelial Reversion, and Metastatic Colonization
0301 basic medicine
Epithelial-Mesenchymal Transition
Lung Neoplasms
QH301-705.5
Cell Survival
Nude
610
Mice, Nude
Smad Proteins
Breast Neoplasms
Mice, Transgenic
Transgenic
Article
Cell Line
Mice
03 medical and health sciences
Transforming Growth Factor beta
Cell Line, Tumor
Proto-Oncogene Proteins
616
Animals
Humans
Biology (General)
Neoplasm Metastasis
Homeodomain Proteins
Transplantation
Heterologous
Tumor
Animal
CD24 Antigen
Receptor Protein-Tyrosine Kinases
Triazoles
3. Good health
Benzocycloheptenes
Disease Models, Animal
Disease Models
Neoplastic Stem Cells
Female
RNA Interference
Thrombospondins
Signal Transduction
DOI:
10.1016/j.celrep.2015.11.025
Publication Date:
2015-12-06T13:21:45Z
AUTHORS (11)
ABSTRACT
During metastatic colonization, tumor cells must establish a favorable microenvironment or niche that will sustain their growth. However, both the temporal and molecular details of this process remain poorly understood. Here, we found that metastatic initiating cells (MICs) exhibit a high capacity for lung fibroblast activation as a result of Thrombospondin 2 (THBS2) expression. Importantly, inhibiting the mesenchymal phenotype of MICs by blocking the epithelial-to-mesenchymal transition (EMT)-associated kinase AXL reduces THBS2 secretion, niche-activating ability, and, consequently, metastatic competence. Subsequently, disseminated metastatic cells revert to an AXL-negative, more epithelial phenotype to proliferate and decrease the phosphorylation levels of TGF-β-dependent SMAD2-3 in favor of BMP/SMAD1-5 signaling. Remarkably, newly activated fibroblasts promote this transition. In summary, our data reveal a crosstalk between cancer cells and their microenvironment whereby the EMT status initially triggers and then is regulated by niche activation during metastatic colonization.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (38)
CITATIONS (201)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....